Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.

Continue ReadingProf. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference

Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"

Continue ReadingHarm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed

The CoEHAR smile operation has started: enrolled the first patient of Smile Study

With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).

Continue ReadingThe CoEHAR smile operation has started: enrolled the first patient of Smile Study

Vaping: necessary clinic and functional indicators to assess tobacco harm reduction and related benefits

Tobacco harm reduction theories and their fundamental principles are questioned worldwide. New indicators specifically designed to establish the harm reduction potential of low risk tobacco products are examined by CoEHAR, with promising results

Continue ReadingVaping: necessary clinic and functional indicators to assess tobacco harm reduction and related benefits

Ecigs and Heated Tobacco Products: an innovative new CoEHAR study assesses the harm reversal on respiratory cilia

For the first time, CoEHAR researchers used the saccharin test transit time to compare the data on the regeneration of respiratory cilia among current, former and never smokers, electronic cigarette users and heated tobacco products users. The results suggest that combustion-free nicotine delivery technologies are unlikely to have detrimental effects on mucociliary clearance

Continue ReadingEcigs and Heated Tobacco Products: an innovative new CoEHAR study assesses the harm reversal on respiratory cilia

CoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%

According to the latest study by COEHAR laboratories within the University of Catania, conducted by a group coordinated by Professor Riccardo Polosa, the risk of Covid-19 transmission with vaping is negligible, equal to 1%

Continue ReadingCoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%

International Meeting on Catania Conversation discussed Public Health and future opportunities for 2021

"Vaping and COVID19: What are some of the key scientific learnings for public health and vaping as we prepare for 2021? What can we do better from patients’ perspectives?" the title of the event of last 16th December, where some of the most important names in the field of Harm Reduction discussed different topics, including the Public Health Response to the Covid-19 pandemic

Continue ReadingInternational Meeting on Catania Conversation discussed Public Health and future opportunities for 2021